MarginsXMarginsX
Home › Markets › Health Care › DXR

Daxor Corporation (DXR)

DXR trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$8.36
-0.89% on the day
Market cap
$48.8M
Nano cap
Revenue
No annual revenue filed since the period ending 2011-12-31
Net income
No annual revenue filed since the period ending 2011-12-31

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerDXR on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000027367
Incorporated inNY

Financials

No annual revenue filed since the period ending 2011-12-31.

Warning signs

Cash runway
0.2 months
$60K cash at December 31, 2011
Share count, 1 year
See the dilution note
Going-concern doubt
No recent 10-K, 10-Q or 20-F
Insider net buying, 12 months
$19K
Through September 30, 2026
SignFindingSource
Going concernNo recent periodic reportNone on EDGAR
Cash and burn$60K cash; operating cash flow -$1.2M a quarter.Report 2011-12-31
Shares outstandingNo cover-page share count in XBRLNone on EDGAR
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorBush & Associates CPA LLC, Las Vegas, Nevada, United StatesPCAOB Form AP 2026-03-05
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $19K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q4 2011
2011-12-31
$370K-$1.5M-$990K$60KNo debt tags$1.4M10-K 2012-03-28
Q3 2011
2011-09-30
$341K-$4.2M-$613K$30KNo debt tagsNeeds four quarters10-Q 2011-11-14
Q2 2011
2011-06-30
$358K-$185KNot filed$112KNo debt tagsNeeds four quarters10-Q/A 2011-08-31
Q4 2010
2010-12-31
$361K$2.3M-$1.8M$58KNo debt tags$1.6M10-K 2012-03-28
Q3 2010
2010-09-30
$453K$2.6M-$1.2M$107KNo debt tagsNeeds four quarters10-Q 2011-11-14
Q2 2010
2010-06-30
$368K$188KNot filed$213KNo debt tagsNeeds four quarters10-Q/A 2011-08-31

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42026-01-26
Latest annual report
FORM 10-K
10-K2012-03-28
Latest quarterly / interim
FORM 10-Q
10-Q2011-11-14
Latest current report8-K2026-06-24
Latest proxyDEF 14A2026-06-03

Source: SEC EDGAR submissions feed, 738 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+0.4%
1 month-18.1%
3 months-18.5%
Year to date-42.5%
1 year-32.3%
From 52-week high-42.5%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
ADGMAdagio Medical Holdings Inc$1.61-16.58%$44.2M
MBOTMicrobot Medical Inc.$0.6444-34.16%$43.3M
MDAISpectral AI Inc.$1.31+0.77%$42.2M
SRTSSensus Healthcare Inc.$2.34+0.65%$38.5M
QTEXQTREX Quantum Ltd.$1.15-8.00%$64.4M
LNSRLENSAR Inc.$5.29+5.80%$65.0M
TELATELA Bio Inc.$0.7616-7.13%$34.4M
NEPHNephros Inc.$3.00-1.64%$32.6M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier